PREZISTA- darunavir tablet, film coated Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

prezista- darunavir tablet, film coated

remedyrepack inc. - darunavir ethanolate (unii: 33o78xf0bw) (darunavir - unii:yo603y8113) - darunavir 600 mg - prezista ® , co-administered with ritonavir (prezista/ritonavir), in combination with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (hiv-1) infection in adult and pediatric patients 3 years of age and older [see use in specific populations (8.4) and clinical studies (14)] . co-administration of prezista/ritonavir is contraindicated with drugs that are highly dependent on cyp3a for clearance and for which elevated plasma concentrations are associated with serious and/or life-threatening events (narrow therapeutic index). these drugs and other contraindicated drugs (which may lead to reduced efficacy of darunavir) are listed in table 6 . due to the need for co-administration of prezista with ritonavir, please refer to ritonavir prescribing information for a description of ritonavir contraindications. co-administration of prezista/ritonavir is contraindicated with drugs that are highly dependent on cyp3a for clearance and for which elevated plasma concentrations are

PREZISTA darunavir tablet film coated Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

prezista darunavir tablet film coated

avera mckennan hospital - darunavir ethanolate (unii: 33o78xf0bw) (darunavir - unii:yo603y8113) - darunavir 800 mg

NORVIR ritonavir tablet film coated Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

norvir ritonavir tablet film coated

avera mckennan hospital - ritonavir (unii: o3j8g9o825) (ritonavir - unii:o3j8g9o825) - ritonavir 100 mg

ASTAGRAF XL- tacrolimus extended-release capsules capsule, coated, extended release Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

astagraf xl- tacrolimus extended-release capsules capsule, coated, extended release

astellas pharma us, inc. - tacrolimus (unii: wm0haq4wnm) (tacrolimus anhydrous - unii:y5l2157c4j) - tacrolimus anhydrous 0.5 mg - astagraf xl® is indicated for the prophylaxis of organ rejection in kidney transplant patients in combination with other immunosuppressants in adult and pediatric patients who can swallow capsules intact [see use in specific populations (8.4) and clinical studies (14.1), (14.2)]. astagraf xl is contraindicated in patients with known hypersensitivity to tacrolimus [see adverse reactions (6.2)] . pregnancy exposure registry there is a pregnancy registry that monitors pregnancy outcomes in women exposed to astagraf xl during pregnancy. the transplantation pregnancy registry international (tpri) is a voluntary pregnancy exposure registry that monitors outcomes of pregnancy in female transplant recipients and those fathered by male transplant recipients exposed to immunosuppressants including tacrolimus. healthcare providers are encouraged to advise their patients to register by contacting the transplantation pregnancy registry international at 1-877-955-6877 or https://www.transplantpregnancyregistry.org/. risk

KALETRA- lopinavir and ritonavir tablet, film coated Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

kaletra- lopinavir and ritonavir tablet, film coated

doh central pharmacy - lopinavir (unii: 2494g1jf75) (lopinavir - unii:2494g1jf75), ritonavir (unii: o3j8g9o825) (ritonavir - unii:o3j8g9o825) - lopinavir 200 mg - kaletra is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection. the following points should be considered when initiating therapy with kaletra: - the use of other active agents with kaletra is associated with a greater likelihood of treatment response [see clinical pharmacology (12.4) and clinical studies (14)] . - genotypic or phenotypic testing and/or treatment history should guide the use of kaletra [see clinical pharmacology (12.4)] . the number of baseline primary protease inhibitor mutations affects the virologic response to kaletra [see clinical pharmacology (12.4)] . - once daily administration of kaletra is not recommended for therapy-experienced adult patients or any pediatric patients. ● kaletra is contraindicated in patients with previously demonstrated clinically significant hypersensitivity (e.g., stevens-johnson syndrome, erythema multiforme) to any of its ingredients, including ritonavir. ●  co-administration of kaletra is contraindicated with drugs t

NORVIR ritonavir tablet film coated Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

norvir ritonavir tablet film coated

remedyrepack inc. - ritonavir (unii: o3j8g9o825) (ritonavir - unii:o3j8g9o825) - ritonavir 100 mg

NORVIR ritonavir capsule Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

norvir ritonavir capsule

abbvie inc. - ritonavir (unii: o3j8g9o825) (ritonavir - unii:o3j8g9o825) - ritonavir 100 mg

AZITHROMYCIN tablet, film coated Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

azithromycin tablet, film coated

teva pharmaceuticals usa, inc. - azithromycin monohydrate (unii: jte4mnn1md) (azithromycin anhydrous - unii:j2klz20u1m) - azithromycin anhydrous 600 mg - azithromycin tablets are a macrolide antibacterial drug indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. prophylaxis of disseminated mycobacterium avium complex (mac) disease azithromycin tablets, taken alone or in combination with rifabutin at its approved dose, are indicated for the prevention of disseminated mac disease in persons with advanced hiv infection [see dosage and administration (2)] . treatment of disseminated mac disease azithromycin tablets, taken in combination with ethambutol, are indicated for the treatment of disseminated mac infections in persons with advanced hiv infection [see use in specific populations (8.4) and clinical studies (14.1)] . to reduce the development of drug-resistant bacteria and maintain the effectiveness of azithromycin tablets and other antibacterial drugs, azithromycin tablets should be used only to treat infections that are proven

ZITHROMAX- azithromycin dihydrate tablet, film coated
ZITHROMAX- azithromycin dihydrate powder, for suspension Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

zithromax- azithromycin dihydrate tablet, film coated zithromax- azithromycin dihydrate powder, for suspension

pfizer laboratories div pfizer inc - azithromycin dihydrate (unii: 5fd1131i7s) (azithromycin anhydrous - unii:j2klz20u1m) - azithromycin anhydrous 600 mg - zithromax is a macrolide antibacterial drug indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. non-gonococcal urethritis and cervicitis due to chlamydia trachomatis prophylaxis of disseminated mycobacterium avium complex (mac) disease zithromax, taken alone or in combination with rifabutin at its approved dose, is indicated for the prevention of disseminated mac disease in persons with advanced hiv infection [see dosage and administration (2)]. treatment of disseminated mac disease zithromax, taken in combination with ethambutol, is indicated for the treatment of disseminated mac infections in persons with advanced hiv infection [see use in specific populations (8.4) and clinical studies (14.1)]. to reduce the development of drug-resistant bacteria and maintain the effectiveness of zithromax and other antibacterial drugs, zithromax should be used only to treat infections that are prove